For some patients with advanced blood cancers, enrolling in hospice care can mean forgoing access to palliative transfusions that can help alleviate fatigue, shortness of breath or bleeding related to low blood counts.
Thomas LeBlanc, MD, MA, a hematologic oncologist at Duke Cancer Center who treats patients with acute leukemias and various myeloid diseases and is board-certified in hospice and palliative medicine, described this scenario—deciding between palliative transfusions or home-based hospice care—as an “awful, impossible choice” for patients and their families. Patients may be told they can continue supportive care, including transfusions and antimicrobials, to help manage debilitating symptoms. But they may also be told they cannot elect hospice if they want to continue transfusions.
“In many areas, patients can’t do both,” he said. “I’ve seen several cases where patients were incredibly distraught about being forced to give up transfusions and felt it was unfair to choose between receiving help at home through hospice services and continuing transfusions that made them feel better. It becomes a deeply distressing situation. When we’re able to offer both, you can see the relief. It’s palpable.”
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Meghan Delaney, DO, MPH
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement Officer
Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
